GBI – Pharmaceutical & Biotechnology Data, Intelligence, Consulting

						SOURCE LOGIN \| 中文版

CONSULTING

ADVISORY

SALES FORCE

HOME >SERVICES

China’s pharmaceutical market is rapidly changing and highly competitive. To be successful, companies must rely on partners that have access to deep industry data, years of on the ground experience, and an understanding of broad healthcare industry trends. GBI provides professional services designed to help clients understand and act within the competitive landscape.

GBI has worked with a wide set of healthcare firms to achieve their goals in China. Whether bringing new products to China, screening for acquisition targets, engaging in licensing activities, targeting a sales force, or understanding China’s R&D landscape, clients partner with us to access our experience and unique insights.

GBI focuses exclusively on the pharmaceutical, healthcare, and biotechnology industrires in China.With an understanding of ongoing policy shifts, a global perspective, and a granular knowledge of China's marketplace, players, and practies, GBI maintains a substantial...

Healthcare focused advisory
GBI is a specialized healthcare advisory firm focused on China. Our services are informed by years on the ground in China and supported by deep understanding and unparalleled networks in the healthcare, pharmaceutical, and biotechnology sectors.

Leveraging our robust physician and hospital datasets, we provide specialized targeting services and data for clients. Whether you are planning to launch a niche product to a highly specialized set of hospitals and physicians or need to extend a legacy cardiovascular product into new regions...